Remove Big Data Remove Doctors Remove Regulation Remove Research
article thumbnail

AI, big data and real world evidence – the challenges and opportunities

pharmaphorum

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations in medicine. But, until recently, an important data source has been locked up in the electronic health record (EHR), often in the form of unstructured or ‘free’ text entered by healthcare professionals.

Big Data 127
article thumbnail

Inside the European mass shift to data-driven health solutions

Pharmaceutical Technology

In a few weeks, the EU-funded research project Darwin EU will announce its first batch of data partners for the ambitious real-world data -driven Horizon 2020 project. A major objective of this project hinges on exploiting national EHR data to complete observational studies quicker than industry standards.

Big Data 278
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The rise of real-world evidence: unlocking the potential in EHRs

pharmaphorum

International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health records (EHRs) using artificial intelligence (AI) and clinical Natural Language Processing (NLP) techniques. There is a lot of valuable information that was lost to me. “I

Doctors 107
article thumbnail

Medical Informatics and Rare Disease: a bridge between two worlds

pharmaphorum

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Navigating rare disease research and treatment.

Genome 101
article thumbnail

Healthcare in 2021: Top Disruptions Bound To Impact The Way Healthcare Is Delivered

Delveinsight

The use is limited to advanced hospitals and research facilities and in some developed countries. The wearables collect and analyze users’ real-time medical data, which is more comfortable for physicians and doctors to examine. With each passing day, wearable technology is in significant demand among fitness enthusiasts.

Doctors 52
article thumbnail

Kiromic Announces the Filing of Key European Patents for Its Chimeric PD-1 (chPD1) Target

The Pharma Data

Barber is an associate professor of biology and director of the Office of Student Research. Her research focuses on determining the role costimulatory domains play in enhancing chimeric T-cell activity and the creation and testing of the chPD1 receptor as a therapy for multiple types of cancer. Dr. Barber is a tumor immunologist.

In-Vivo 40